UnitedHealth Group Incorporated (UNH) — Fair Value Analysis

Base-case fair value (P50): $367.68 · Current price: $393.85 · Verdict: Fairly Valued

The Verdict on UNH

UnitedHealth Group (UNH) is currently assessed as Fairly Valued, despite its $379.98 share price trading above our Monte Carlo simulation's median fair value (P50) of $359.10. This represents a -5.5% difference, indicating a modest premium relative to our central valuation estimate derived from thousands of simulated forward scenarios. Our analysis suggests that while the current market price exceeds the statistical median of $359.10, it remains within a range where the company is not considered significantly over or undervalued based on this robust simulation framework, confirming its Fairly Valued status.

How UNH stacks up against Healthcare

UNH's operational and financial health is categorized as an average quality tier compared to the broader Healthcare sector. This assessment of average quality, observed against the current $379.98 market price and our $359.10 median fair value, implies that the company's fundamentals are generally in line with its industry peers. The -5.5% difference between the current price and our P50 further grounds this assessment, suggesting no extreme deviation that would challenge UNH's standing within its sector's typical valuation parameters or indicate a fundamental disconnect from its sector performance.

What this means for investors

For investors, UNH's Fairly Valued status, with its current $379.98 price trading -5.5% above the $359.10 median fair value, signals a market that largely reflects the company's underlying fundamentals. While there's a slight premium to our P50, it doesn't immediately suggest a strong overvaluation or undervaluation in isolation. Investors interested in exploring potential downside or bull case scenarios, beyond this median assessment derived from Monte Carlo simulations, should consider the full distribution of outcomes. FairCurve provides a comprehensive view of these simulations. To see the full bear/bull distribution and track UNH's fair value as new fundamentals are released, sign up for a free FairCurve account.

Frequently Asked Questions

Is UNH overvalued or undervalued right now?

UnitedHealth Group (UNH) is currently assessed as Fairly Valued. Its current price of $379.98 trades slightly above our median fair value (P50) of $359.10.

What is the bear case and bull case for UNH?

The full Monte Carlo distribution, including bear (P10) and bull (P90) targets, plus the probability of upside, is available with a free FairCurve account. These detailed scenarios are crucial for a complete risk-reward assessment.

How does FairCurve calculate UNH's fair value?

FairCurve calculates UNH's fair value using sophisticated Monte Carlo simulations, running thousands of forward scenarios to determine a comprehensive distribution of potential valuations.

How can I track UNH's fair value as it changes?

You can add UNH to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuation when new earnings or significant fundamental news are released.